TCR2 Therapeutics Inc (NASDAQ:TCRR)

1.60
Delayed Data
As of May 26
 -0.15 / -8.57%
Today’s Change
0.82
Today|||52-Week Range
3.88
+60.19%
Year-to-Date
No recent news for TCR2 Therapeutics Inc.

Today’s Trading

Previous close1.75
Today’s open1.72
Day’s range1.55 - 1.72
Volume35,002
Average volume (3 months)484,612
Market cap$73.4M
Data as of 3:59pm ET, 05/26/2023

Growth & Valuation

Earnings growth (last year)-49.39%
Earnings growth (this year)+30.64%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.52

Competitors

----
----
--Herantis Pharma Oyj0.000.00%
ABEOAbeona Therapeutics ...-0.12-3.74%
Data as of 3:59pm ET, 05/26/2023

Financials

Next reporting dateAugust 9, 2023
EPS forecast (this quarter)-$0.79
Annual revenue (last year)$0.00
Annual profit (last year)-$151.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts